BA

BEHAVIORAL2 trials

Sponsors

University of Illinois at Chicago, Butler Hospital

Conditions

Bipolar Disorder (BD)Dysplastic Nevus Syndrome

Phase 1

Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

WithdrawnNCT00346502

University of Illinois at ChicagoDysplastic Nevus Syndrome

Start: 2006-01-31End: 2015-12-31Updated: 2021-06-28

Unknown Phase

Project MOVE Bipolar

CompletedNCT07767032

Butler HospitalBipolar Disorder (BD)

Start: 2018-01-18End: 2020-04-02Updated: 2026-08-17

Related Papers

PD25-11 ANTI-INFLAMMATORY EFFECT OF BETULINIC ACID IS DEPENDENT ON METABOLIC REPROGRAMMING OF IMMUNE CELLS

The Journal of Urology2024-04-151 citations